1,082 top medical experts on Diabetic Angiopathies across 68 countries and 41 U.S. states, including 1,004 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Diabetic Angiopathies: vascular diseases that are associated with diabetes mellitus.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Diabetes Complications (4,287), Vascular Diseases (4,192) and Narrower Categories: Diabetic Foot (3,369), Diabetic Retinopathy (3,855).
  4. Clinical Trials ClinicalTrials.gov : at least 21 including 10 Completed, 3 Recruiting
  5. Synonyms: Diabetic Vascular Complications,  Diabetic Vascular Diseases,  Diabetic Microangiopathy


  

        

                    


    These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads, screen scraping or using the data) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

  1. Cushman, William C   Internal Medicine  Google Publications
    Memphis Veterans Affairs Medical Center, Memphis, TN, USA.
    Physician  Highly Cited  Highly Published  Clinical Trial 
    Disclosed payments from biomedical company (SANOFI-AVENTIS U.S. LLC) in 2021 for $20.53
    Subjects: Diabetes Mellitus, Type 2; Hypoglycemic Agents; Cardiovascular Diseases; Glucagon-Like Peptides; Immunoglobulin Fc Fragments
    Categories: Therapeutic Use; Drug Therapy; Prevention & Control; Analogs & Derivatives; Complications; Adverse Effects
    Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. (2010)
    Diabetes and hypertension: the bad companions. (2012)

  2. King, George L   Endocrinology, Diabetes & Metabolism   Google Publications
    Dianne Nunnally Hoppes Laboratory for Diabetes Complications, Section of Vascular Cell Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA, 02215, USA. Electronic address: . Top Hospital
    Physician  Highly Cited  Highly Published 
    Medical school: Duke University School of Medicine (MD, 1975)
    Medicare Accepted
    Disclosed payments from biomedical company (Medtronic, Inc.) in 2021 for $2,700
    Subjects: Diabetes Mellitus, Type 1; Blood Glucose; Cardiovascular Diseases; Cognition Disorders; Diabetes Mellitus, Type 2
    Categories: Epidemiology; Metabolism; Blood; Complications; Enzymology; Etiology
    Activation of protein kinase C isoforms and its impact on diabetic complications. (2010)
    Diabetic Microvascular Disease: An Endocrine Society Scientific Statement. (2017)

  3. Basile, Jan N   Internal Medicine   Google Publications
    Medical University of South Carolina, Ralph H Johnson VA Medical Center, Charleston, SC, USA.
    Physician  Highly Cited  Clinical Trial 
    Disclosed payments in 2021 from 42 biomedical companies, totalling $23,046.2, including $21,000 from  Eli Lilly and Company
    Subjects: Diabetes Mellitus, Type 2; Hypoglycemic Agents; Cardiovascular Diseases; Diabetic Cardiomyopathies; Glucagon-Like Peptides
    Categories: Therapeutic Use; Prevention & Control; Drug Therapy; Analogs & Derivatives; Administration & Dosage; Analysis
    Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. (2010)
    Design and baseline characteristics of participants in the Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) trial on the cardiovascular effects of dulaglutide. (2018)

  4. Buse, John B   Endocrinology, Diabetes & Metabolism  Google Publications
    Division of Endocrinology and Metabolism, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC.
    Physician  Highly Cited  Highly Published  Clinical Trial 
    Medical school: Duke University School of Medicine (MD, 1986)
    Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 76/100
    Disclosed payments in 2021 from 12 biomedical companies, totalling $41,875, including $24,375 from  Novo Nordisk AS
    Subjects: Diabetes Mellitus, Type 2; Cardiovascular Diseases; Hypoglycemia; Hypoglycemic Agents; Exenatide
    Categories: Prevention & Control; Drug Therapy; Therapeutic Use; Epidemiology; Diagnosis; Blood
    The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. (2010)
    The hemoglobin glycation index identifies subpopulations with harms or benefits from intensive treatment in the ACCORD trial. (2015)

  5. Bergenstal, Richard M   Endocrinology, Diabetes & Metabolism   Google Publications
    International Diabetes Center, Park-Nicollet Clinic, Minneapolis, Minnesota.
    Physician  Highly Cited  Clinical Trial 
    Disclosed payments in 2021 from 38 biomedical companies, totalling $54,990.54, including $31,710 from  Eli Lilly and Company
    Subjects: Diabetes Mellitus, Type 2; Hypoglycemic Agents; Cardiovascular Diseases; Glycated Hemoglobin A; Hypoglycemia
    Categories: Drug Therapy; Therapeutic Use; Mortality; Adverse Effects; Complications; Metabolism
    The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. (2010)
    The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study. (2010)

  6. Inzucchi, Silvio E   Endocrinology, Diabetes & Metabolism   Google Publications
    Section of Endocrinology, Yale University School of Medicine, New Haven, CT . Top Hospital
    Physician  Highly Cited  Clinical Trial 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 68/100
    Disclosed payments in 2021 from 41 biomedical companies, totalling $60,136.48, including $13,345 from  Novo Nordisk AS
    Subjects: Diabetes Mellitus, Type 2; Cardiovascular Diseases; Hypoglycemic Agents; Aspirin; Benzhydryl Compounds
    Categories: Prevention & Control; Therapeutic Use; Drug Therapy; Complications; Mortality; Administration & Dosage
    How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial. (2018)
    Individualizing glycemic targets in type 2 diabetes mellitus: implications of recent clinical trials. (2011)

  7. Angiolillo, Dominick J   Interventional Cardiology   Google Publications
    University of Florida College of Medicine-Jacksonville, 655 W. Eighth Street, Jacksonville, FL 32209, USA.  Top Hospital
    Physician  Clinical Trial 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 84/100
    Disclosed payments in 2021 from 11 biomedical companies, totalling $30,241, including $15,151 from  SANOFI-AVENTIS U.S. LLC
    Subjects: Coronary Artery Disease; Platelet Aggregation Inhibitors; Diabetes Mellitus, Type 2; Blood Platelets; Acute Coronary Syndrome
    Categories: Drug Therapy; Administration & Dosage; Therapeutic Use; Analogs & Derivatives; Prevention & Control; Blood
    Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial. (2010)
    A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 Trial. (2011)

  8. Ponikowski, Piotr    Google Publications
    Department of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland; and Centre for Heart Diseases, Military Hospital, Wroclaw, Poland.
    Physician  Highly Cited  Guideline 
    Subjects: Diabetes Mellitus, Type 2; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Hypoglycemia; Hypoglycemic Agents
    Categories: Prevention & Control; Chemically Induced; Adverse Effects
    ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). (2013)
    ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). (2013)

  9. Riddle, Matthew C   Endocrinology, Diabetes & Metabolism   Google Publications
    Department of Medicine, Oregon Health & Science University Portland, OR, USA. Top Hospital
    Physician  Clinical Trial 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 80.3/100
    Disclosed payments from biomedical company (SANOFI-AVENTIS U.S. LLC) in 2021 for $715
    Subjects: Diabetes Mellitus, Type 2; Hypoglycemic Agents; Glucagon-Like Peptides; Immunoglobulin Fc Fragments; Recombinant Fusion Proteins
    Categories: Therapeutic Use; Prevention & Control; Drug Therapy; Adverse Effects; Chemically Induced; Analogs & Derivatives
    Design and baseline characteristics of participants in the Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) trial on the cardiovascular effects of dulaglutide. (2018)
    Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial. (2013)

  10. Mills, Joseph L   Vascular Surgery  Google Publications
    Surgery, Baylor College of Medicine, Houston, TX, USA. Top Hospital
    Physician  Guideline  Review 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 75.8/100
    Disclosed payments in 2021 from 3 biomedical companies, totalling $60.05, including $60.05 from  Medline Industries, Inc.
    Subjects: Ischemia; Evidence-Based Medicine; Arterial Occlusive Diseases; Diabetic Foot; Leg
    Categories: Therapy; Blood Supply; Diagnosis; Physiopathology; Surgery; Etiology
    IWGDF guidance on the diagnosis, prognosis and management of peripheral artery disease in patients with foot ulcers in diabetes. (2016)
    Effectiveness of bedside investigations to diagnose peripheral artery disease among people with diabetes mellitus: a systematic review. (2016)

  11. Plutzky, Jorge   Cardiovascular Disease   Google Publications
    Preventive Cardiology, Cardiovascular Medicine, Brigham and Womens Hospital, Shapiro Cardiovascular Centre, Boston, MA, USA. Top Hospital
    Physician 
    Medical school: University of North Carolina at Chapel Hill School of Medicine (MD, 1986)
    Medicare Accepted
    Disclosed payments in 2021 from 5 biomedical companies, totalling $22,241.32, including $9,616.32 from  VIVUS LLC
    Subjects: Diabetes Mellitus; Diabetes Mellitus, Type 2; PPAR alpha; PPAR gamma; Antibodies, Monoclonal
    Categories: Drug Therapy; Metabolism; Agonists; Genetics; Pharmacology; Prevention & Control
    Epigenetic Changes in Diabetes and Cardiovascular Risk. (2016)
    Modulating peroxisome proliferator-activated receptors for therapeutic benefit? Biology, clinical experience, and future prospects. (2012)

  12. Bjornstad, Petter   Pediatric Endocrinology   Google Publications
    University of Colorado Anschutz Medical Campus and Childrens Hospital Colorado, Aurora, CO.
    Physician  Clinical Trial 
    Disclosed payments in 2021 from 10 biomedical companies, totalling $10,397.09, including $5,280 from  Eli Lilly and Company
    Subjects: Diabetes Mellitus, Type 1; Coronary Artery Disease; Diabetic Nephropathies; Atherosclerosis; Uric Acid
    Categories: Complications; Diagnosis; Epidemiology; Blood; Prevention & Control; Physiology
    Elevated Serum Uric Acid Is Associated With Greater Risk for Hypertension and Diabetic Kidney Diseases in Obese Adolescents With Type 2 Diabetes: An Observational Analysis From the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study. (2019)
    Serum uric acid predicts vascular complications in adults with type 1 diabetes: the coronary artery calcification in type 1 diabetes study. (2014)

  13. Fonseca, Vivian A   Endocrinology, Diabetes & Metabolism   Google Publications
    Department of Medicine, Tulane University Health Sciences Center, New Orleans, LA.
    Physician  Clinical Trial 
    Medical school: Other (MD, 1976)
    Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 75.8/100
    Disclosed payments in 2021 from 43 biomedical companies, totalling $82,639.43, including $23,810 from  SANOFI-AVENTIS U.S. LLC
    Subjects: Diabetes Mellitus, Type 2; Hypoglycemic Agents; Allylamine; Anticholesteremic Agents; Blood Glucose
    Categories: Prevention & Control; Diagnosis; Therapeutic Use; Drug Therapy; Adverse Effects; Drug Effects
    The hemoglobin glycation index identifies subpopulations with harms or benefits from intensive treatment in the ACCORD trial. (2015)
    Colesevelam lowers glucose and lipid levels in type 2 diabetes: the clinical evidence. (2010)

  14. Solomon, Scott D   Cardiovascular Disease   Google Publications
    Cardiovascular Medicine Division, Department of Medicine, Brigham and Womens Hospital, Harvard Medical School, Boston, MA. Top Hospital
    Physician  Clinical Trial 
    Medical school: Harvard Medical School (MD, 1986)
    Medicare Accepted
    Disclosed payments in 2021 from 13 biomedical companies, totalling $67,472, including $26,730 from  GlaxoSmithKline, LLC.
    Subjects: Diabetes Mellitus, Type 2; Diabetic Nephropathies; Renal Insufficiency, Chronic; Cardiovascular Diseases; Darbepoetin alfa
    Categories: Mortality; Prevention & Control; Therapeutic Use; Physiopathology; Drug Therapy; Analogs & Derivatives
    Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease. (2019)
    Influenza Vaccination Is Associated With Reduced Cardiovascular Mortality in Adults With Diabetes: A Nationwide Cohort Study. (2020)

  15. Abbott, Jinnette Dawn   Interventional Cardiology   Google Publications
    Lifespan Cardiovascular Institute, Rhode Island Hospital, Providence, RI, USA.
    Physician  Clinical Trial  Review 
    Medical school: University of Chicago, Pritzker School of Medicine (MD, 1995)
    Medicare Accepted
    Disclosed payments in 2021 from 8 biomedical companies, totalling $3,847.7, including $3,150 from  Medtronic, Inc.
    Subjects: Coronary Artery Disease; Angioplasty, Balloon, Coronary; Diabetes Mellitus, Type 2; Drug-Eluting Stents; Absorbable Implants
    Categories: Mortality; Etiology; Therapy; Administration & Dosage; Surgery; Complications
    Risk factors for incident peripheral arterial disease in type 2 diabetes: results from the Bypass Angioplasty Revascularization Investigation in type 2 Diabetes (BARI 2D) Trial. (2014)
    Ankle-brachial index and cardiovascular outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial. (2012)

  16. Margolis, David J   Dermatology   Google Publications
    Department of Biostatistics and Epidemiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA . Top Hospital
    Physician 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 78/100
    Disclosed payments in 2021 from 6 biomedical companies, totalling $21,461.5, including $17,261.5 from  PFIZER INC.
    Subjects: Amputation; Adaptor Proteins, Signal Transducing; African Americans; Coronary Artery Disease; Diabetes Mellitus, Type 2
    Categories: Mortality; Epidemiology; Genetics; Statistics & Numerical Data; Surgery
    Diabetes, lower-extremity amputation, and death. (2015)
    Diabetes, lower extremity amputation, loss of protective sensation, and neuronal nitric oxide synthase associated protein in the chronic renal insufficiency cohort study. (2013)

  17. Califf, Robert M   Cardiovascular Disease  Google Publications
    Duke Translational Medicine Institute, Duke University Medical Center, Durham, NC. Top Hospital
    Physician  Clinical Trial 
    Disclosed payments from biomedical company (Medtronic, Inc.) in 2021 for $73
    Subjects: Diabetes Mellitus, Type 2; Cardiovascular Diseases; Hypoglycemic Agents; Coronary Disease; Diabetic Cardiomyopathies
    Categories: Drug Therapy; Prevention & Control; Therapeutic Use; Physiopathology; Surgery; Physiology
    Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes. (2014)
    Regional, age and sex differences in baseline characteristics of patients enrolled in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS). (2015)

  18. Arterburn, David E   Internal Medicine  Google Publications
    Kaiser Permanente Washington Health Research Institute, Seattle, Washington D.A..
    Physician 
    Subjects: Obesity, Morbid; Bariatric Surgery; Diabetes Mellitus, Type 2; Cardiovascular Diseases
    Categories: Complications; Prevention & Control; Surgery; Adverse Effects
    Microvascular Outcomes in Patients With Diabetes After Bariatric Surgery Versus Usual Care: A Matched Cohort Study. (2018)
    Clinical Outcomes of Metabolic Surgery: Microvascular and Macrovascular Complications. (2016)

  19. Bhatt, Deepak L   Interventional Cardiology   Google Publications
    TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Womens Hospital, and Harvard Medical School, Boston, Massachusetts. Top Hospital
    Physician  Clinical Trial 
    Medical school: Js Weill Medical College, Cornell University (MD, 1993)
    Medicare Accepted
    Disclosed payments in 2021 from 32 biomedical companies, totalling $169,114.48, including $51,540 from  PFIZER INC.
    Subjects: Diabetes Mellitus, Type 2; Diabetes Mellitus; Acute Coronary Syndrome; Benzhydryl Compounds; Cardiovascular Diseases
    Categories: Drug Therapy; Therapeutic Use; Prevention & Control; Therapy; Complications
    DECLARE-TIMI 58: Participants' baseline characteristics. (2018)
    Do dipeptidyl peptidase-4 inhibitors increase the risk of heart failure? (2014)

  20. Smith, Lewis J   Pulmonary Disease  Google Publications
    Departments of Preventive Medicine and Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL. Top Hospital
    Physician  Review 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 86.9/100
    Subjects: Diabetes Mellitus, Type 2; Albuminuria; Blood Pressure; Heart Failure; Hispanic or Latino
    Categories: Physiopathology; Ethnology; Nursing; Complications; Organization & Administration; Physiology
    Nurse-led interventions used to improve control of high blood pressure in people with diabetes: a systematic review and meta-analysis. (2011)
    Hispanics/Latinos With Type 2 Diabetes Have Functional and Symptomatic Pulmonary Impairment Mirroring Kidney Microangiopathy: Findings From the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). (2016)

Note:
  1. Only the top 20 experts are shown. You may filter your results or use the geolocation tabs. Contact us to purchase the entire list.
These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads or screen scraping) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

);